Warner Chilcott Plc (WCRX) is weighing options including a possible sale after receiving interest from strategic and private-equity buyers, according to people with knowledge of the matter. The shares jumped in early trading. Goldman Sachs Group Inc. (GS) is helping the drugmaker assess interest, said the people, who declined to be identified because the discussions are private. Warner Chilcott is also considering paying a dividend as an alternative to a sale, one person said.
